Adverse Events With Magnesium Sulfate

NCT00005448 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-09-08

No results posted yet for this study

Summary

To investigate in pregnant women the adverse pulmonary effects of magnesium sulfate (MgSO4), a commonly used drug for tocolysis or arrest of labor.

Conditions

  • Lung Diseases

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • George Macones · University of Pennsylvania

Eligibility

Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-07-31
Primary Completion
2002-06-30
Completion
2002-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005448 on ClinicalTrials.gov